GPCRs-Targeted Drug Discovery Summit Leaderboard
  • Friday, May 8, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Obesity & Weight Loss Drug Development Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 178

Author

Pharma Journalist 8778 posts 0 comments

Kevzara (sarilumab) Approved by FDA as First and Only Biologic Indicated for Patients with…

Mar 1, 2023
Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration (FDA) has approved Kevzara (sarilumab) for the treatment of polymyalgia rheumatica (PMR),…
Read More...

Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based…

Mar 1, 2023
Sunshine Biopharma Inc. announced the signing of an exclusive worldwide license agreement (the “License Agreement”) with the University of Arizona. The License Agreement grants Sunshine…
Read More...

Tevard Biosciences and Vertex Partner to Create Breakthrough tRNA-Based Treatments for Duchenne…

Mar 1, 2023
Tevard Biosciences, Inc., the pioneer of tRNA-based therapies for severe genetic diseases, announced a four-year global research collaboration with Vertex Pharmaceuticals Incorporated…
Read More...

Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS (Omaveloxolone), the First and Only Drug…

Feb 28, 2023
Reata Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (“FDA”) has approved SKYCLARYS (omaveloxolone) for the treatment of Friedreich’s ataxia in adults and…
Read More...

Tempus Announces New Strategic Collaboration with Pfizer to Advance Oncology Therapeutic Development

Feb 28, 2023
Tempus, a leader in artificial intelligence (AI) and precision medicine, today announced a multi-year, strategic collaboration with Pfizer in which the two companies are working…
Read More...

Rhythm Pharmaceuticals Announces Acquisition of Xinvento B.V. and Portfolio of Investigational…

Feb 28, 2023
Rhythm Pharmaceuticals, Inc. announced that Rhythm’s Netherlands subsidiary, Rhythm Pharmaceuticals Netherlands B.V. (“Rhythm BV”), acquired Xinvento B.V., a Netherlands-based biotech…
Read More...

Azenta Launches Cryo Store Pico, a Novel Automated Cryogenic Storage System Designed for Clinical…

Feb 27, 2023
Azenta, Inc. announced the launch of the Cryo Store Pico™ ("Pico"), a novel automated cryogenic storage system designed for high-value biological samples used in the many stages of life…
Read More...

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ) for the Treatment of Adults with…

Feb 27, 2023
AbbVie announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of upadacitinib (RINVOQ, 45 mg and 15 mg and 30 mg…
Read More...

Singleron Biotechnologies and Macrogen Europe announce a strategic alliance

Feb 27, 2023
Singleron Biotechnologies, a front-runner in single cell multi-omics analysis, and Macrogen Europe, a state-of-the-art sequencing provider of fast and reliable genome analysis services…
Read More...

Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate…

Feb 27, 2023
Ocugen, Inc. announced that it has submitted an Investigational New Drug application (IND) with the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial of…
Read More...
Prev Next
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
GPCRs-Targeted Drug Discovery Summit
5th World ADC Summit South Korea
Extrahepatic Lipid-Based Nanoparticles Delivery Summit
World TPD & Induced Proximity Summit South Korea
Measuring Patient Engagement Summit
Investigative & Preclinical Toxicology Summit 2026
LEAP HR: Life Sciences West
Oligonucleotides for CNS Summit
R&D Procurement & Sourcing in Pharma Summit
In Vivo Cell Engineering & Gene Editing Summit
PFS & Injectable Drug Delivery West Coast
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
World Bispecific & T-Cell Engager Summit South Korea
TCR-Based Therapies Summit
PFS & Injectable Drug Devices East Coast
5th ADC Analytical Development Summit
Nasal Formulation & Delivery Summit
Peptide-Based Therapeutics Summit 2026
ALS Drug Development Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition
  • Madrigal Licenses Gene Therapy Candidate for MASH Treatment
  • Citius Oncology Secures $36.5M to Boost LYMPHIR Launch
  • Latus Bio Raises $97 Million to Advance Gene Therapies
  • FDA Approves LANGLARA Biosimilar Insulin for Diabetes Treatment

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

Turning Biophysical Data into Confident Drug Discovery…

Targeted LNP Delivery Beyond the Liver: The Challenges…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.